No Data
Invivyd to Participate in the Guggenheim Securities Healthcare Innovation Conference
Invivyd to Host Third Quarter 2024 Financial Results and Corporate Update Conference Call on November 14, 2024
This NANO Nuclear Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Invivyd Initiated at Buy by EF Hutton
EF Hutton Initiates Coverage On Invivyd With Buy Rating, Announces Price Target of $9
Morgan Stanley Maintains Invivyd(IVVD.US) With Buy Rating, Maintains Target Price $9.5
No Data
No Data